Franc Strle Selected Research

Lyme Neuroborreliosis

9/2020	Effect of Statin Use on the Clinical Manifestations, Laboratory Test Results and Outcome of Lyme Neuroborreliosis.
12/2015	Lyme neuroborreliosis in a patient treated with TNF-alpha inhibitor.
4/2014	Intrathecally produced IgG and IgM antibodies to recombinant VlsE, VlsE peptide, recombinant OspC and whole cell extracts in the diagnosis of Lyme neuroborreliosis.
8/2013	Suspected early Lyme neuroborreliosis in patients with erythema migrans.
4/2010	Humoral immune responses in patients with Lyme neuroborreliosis.
1/2005	Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Franc Strle Research Topics

Disease

31	Lyme Disease (Disease, Lyme) 01/2021 - 07/2002
30	Erythema 08/2020 - 06/2002
16	Infections 01/2022 - 07/2002
9	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 02/2021 - 08/2005
9	Leukocytosis (Pleocytosis) 01/2018 - 07/2002
8	Thrombocytopenia (Thrombopenia) 02/2022 - 01/2004
7	Tick Bites 04/2021 - 07/2002
6	Lyme Neuroborreliosis 09/2020 - 01/2005
5	Leukopenia 11/2015 - 01/2004
4	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 07/2002
4	Communicable Diseases (Infectious Diseases) 09/2020 - 01/2005
4	Myalgia 01/2018 - 07/2002
3	Disease Progression 02/2021 - 07/2002
3	Fever (Fevers) 01/2021 - 01/2004
3	Bacterial Infections (Bacterial Infection) 01/2021 - 12/2005
3	Hemorrhagic Fever with Renal Syndrome (HFRS) 05/2018 - 06/2005
3	Arthralgia (Joint Pain) 01/2018 - 07/2002
3	Chills 11/2015 - 07/2002
2	Virus Diseases (Viral Diseases) 01/2020 - 12/2005
2	Acrodermatitis (Gianotti Crosti Syndrome) 01/2019 - 07/2002
2	Bronchiolitis 11/2018 - 01/2016
2	Paresis (Hemiparesis) 01/2016 - 11/2006
2	Anaplasmosis 08/2012 - 12/2005
1	Pain (Aches) 01/2022
1	Lymphadenopathy 04/2021
1	COVID-19 01/2021
1	Inflammation (Inflammations) 01/2021
1	Fibromyalgia (Fibrositis) 01/2021
1	Exanthema (Rash) 01/2021
1	Post-Lyme Disease Syndrome 01/2021
1	Birth Weight (Birth Weights) 11/2018
1	Fatigue 01/2018
1	Headache (Headaches) 01/2018
1	Sepsis (Septicemia) 10/2017
1	Critical Illness (Critically Ill) 10/2017
1	Gastroenteritis 01/2016
1	Febrile Seizures (Febrile Seizure) 01/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2015
1	Cough 11/2015
1	Hematologic Neoplasms (Hematological Malignancy) 08/2015
1	Pneumonia (Pneumonitis) 01/2015
1	Staphylococcal Infections 01/2011
1	Q Fever (Fever, Q) 01/2009
1	Acute Disease 11/2006

Drug/Important Bio-Agent (IBA)

28	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 07/2002
19	AntibodiesIBA 04/2021 - 07/2002
16	Immunoglobulin G (IgG)IBA 02/2021 - 07/2002
13	Immunoglobulin M (IgM)IBA 01/2016 - 07/2002
10	Doxycycline (Periostat)FDA LinkGeneric 11/2019 - 07/2002
8	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2018 - 01/2005
7	C-Reactive ProteinIBA 01/2021 - 07/2002
6	AntigensIBA 04/2014 - 07/2002
4	EnzymesIBA 02/2022 - 08/2013
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2002
3	Antiviral Agents (Antivirals)IBA 01/2018 - 05/2015
3	ProcalcitoninIBA 01/2018 - 07/2002
3	ImmunosorbentsIBA 05/2015 - 08/2013
3	1-oleoyl-2-stearoylphosphatidylcholineIBA 04/2014 - 07/2002
3	Azithromycin (Zithromax)FDA LinkGeneric 01/2009 - 06/2002
2	ChemokinesIBA 01/2022 - 02/2014
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2018
2	VaccinesIBA 01/2021 - 11/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2020 - 01/2018
2	Penicillins (Penicillin)FDA Link 08/2020 - 01/2009
2	Adalimumab (Humira)FDA Link 11/2019 - 12/2015
2	RNA (Ribonucleic Acid)IBA 01/2018 - 08/2005
2	Peptides (Polypeptides)IBA 04/2014 - 10/2009
2	cefuroxime axetil (Ceftin)FDA LinkGeneric 01/2010 - 06/2005
1	LigandsIBA 01/2022
1	Chemotactic FactorsIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2019
1	Infliximab (Remicade)FDA Link 11/2019
1	Tumor Necrosis Factor InhibitorsIBA 11/2019
1	golimumab FDA Link 11/2019
1	Rituximab (Mabthera)FDA Link 07/2019
1	Bronchodilator Agents (Bronchodilators)IBA 11/2018
1	ORALIT (ORS)IBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	CreatinineIBA 01/2018
1	InterferonsIBA 01/2018
1	Carbapenems (Carbapenem Antibiotics)IBA 10/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2015
1	Cell ExtractsIBA 04/2014
1	AutoantibodiesIBA 02/2014
1	CytokinesIBA 02/2014
1	Interleukin-23 (Interleukin 23)IBA 02/2014
1	Daptomycin FDA Link 01/2011
1	Pharmaceutical PreparationsIBA 06/2006

Therapy/Procedure

11	Therapeutics 01/2021 - 04/2005
6	Aftercare (After-Treatment) 01/2018 - 06/2005
2	Retreatment 11/2019 - 08/2015
1	Home Nursing (Nursing, Home) 11/2016
1	Elective Surgical Procedures 01/2016
1	Blood Transfusion (Blood Transfusions) 08/2012
1	Cesarean Section (Caesarean Section) 08/2012
1	Length of Stay 11/2006
1	Duration of Therapy 11/2006